Maitake Grifron Maitake D-Fraction – 360 Caps

Maitake Grifron Maitake D-Fraction – 360 caps

Grifron Maitake Mushroom Maitake D-Fraction 360 Capsule Description: Maitake D-Fraction capsules act as an immune booster and a body normalizing adaptogen. Instructions: Additional Info: ?Maitake D-Fraction?? has been developed and commercialized by Maitake Products, Inc. since 1995. ?Maitake D-Fraction?,? a registered trademark for the standardized extract from Maitake mushroom, contains the active ingredient; protein bound ?-glucan complex. This unique active compound makes it very potent in enhancing immune system by oral administration. Being liquid in vegetable glycerin base (alcohol free), ?Maitake D-fraction?? can attain a much faster and much more effective absorption by your body.?-glucan in maitake mushroom has ?-1,6-glucan with ?-1,3 branches and ?-1,3-glucan with ?-1,6 branches. Researchers theorize that this complexity of ?-glucan branching makes Maitake superior to other medicinal mushrooms in immune stimulatory effect. One of the difficulties with many of the medicinal mushrooms is that they lose much of their effectiveness when taken orally. An essential point about our Maitake D-Fraction is that current research indicates it is most effective when taken orally.The professional version of ?Maitake D-Fraction??; ?Grifron?-Pro D-Fraction?? has been used at the Cancer Treatment Centers of America (CTCA) since 1993. At that time, Dr. Robert Atkins, known as the ?pantheon? of the Alternative Medicine in this country began using it at the Atkins Center in New York City for the treatments of various cancer patients. When ?Maitake D-Fraction?? received some strong support by Dr. Andrew Weil, this product became well known among doctors in Alternative Medicine.?Grifron?-Pro D-Fraction?? has received IND (Investigational New Drug Application) approval from the FDA (Food and Drug Administration) to conduct a Phase II study on its effect for advanced breast and prostate cancer patients in 1998. Phase I study for the toxicity has been exempted due to the established safety records both in Japan and the USA. Meanwhile, a researcher group of the Department of Urology at NY Medical College has announced the ?Apoptosis (programmed cell death) inducing? activity by ?Grifron?-Pro D-Fraction?? on human prostatic cancer cells in late 1999. This finding has been published in Molecular Urology (Vol.4, No.1, 2000) and paid keen attention in cancer research and treatment.?Maitake D-Fraction?? is the registered trademark of Maitake Products, Inc.?Maitake D-Fraction?? is our trademark registered with the U.S. Patent and Trademark Office as of October, 1996 for the standardized maitake extract product that has been on the market place since the previous year. There is some misunderstanding among the people or even professionals that ?Maitake D-Fraction?? may be a generic term of active ingredient in Maitake mushroom. Please do not get confused. It is the trademark for the product originated and developed by us. The active compound of maitake mushroom is a po
List Price: 86.35
Price: 51.79